Status: Recruiting
An Open-Label, Double-Treatment Group Study to Evaluate the Efficacy and Safety of Human Allogeneic Bone-Marrow- Derived Mesenchymal Stromal Cell Product StromaForte Compared With Hyaluronic Acid for the Treatment of Knee Osteoarthritis
StromaForte injection for knee OA
Participants needed: 140
Trial details
Phase: Phase 2, Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: Cellcolabs Clinical SPV LimitedUpdated: Apr 21, 2026Locations: 1
Eligibility criteria
Willing and able to provide written informed consent and comply with all procedu... [+5]
Unwilling or unable to perform any of the assessments required by the protocol. [+20]